Organization
Allay Therapeutics
1 clinical trial
Clinical trial
A Phase 2B, Randomized, Double Blind, Active Comparator, Multicenter, Safety, and Efficacy Trial of ATX-101 in Subjects Undergoing Total Knee ArthroplastyStatus: Active (not recruiting), Estimated PCD: 2025-08-31